26
|
Kataoka Y, Hosoda K, Makino H, Matsubara M, Matsuo M, Ohata Y, Koezuka R, Tamanaha T, Tomita T, Honda-Kohmo K, Noguchi M, Son C, Nishimura K, Asaumi Y, Miyamoto Y, Noguchi T, Yasuda S. The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Mellitus (OPTIMAL). Cardiovasc Diagn Ther 2019; 9:431-438. [PMID: 31737515 DOI: 10.21037/cdt.2019.09.02] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Background Patients with type 2 diabetes mellitus (T2DM) are high-risk subjects who more frequently have micro- and macrovascular diseases including coronary artery disease (CAD). Since impaired glycemic homeostasis directly influences the formation and propagation of atherosclerotic plaques, optimal management of glycemic status is required for the prevention of diabetic atherosclerosis. Continuous glucose monitoring (CGM) provides not only average glucose level but also the degree of glucose fluctuation and hypoglycemia. Given the association of glycemic variability with diabetic macrovascular diseases, CGM-based glycemic management could favorably modulate glycemic fluctuation, thereby potentially modifying atheroma burden in T2DM subjects. To test this hypothesis, the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Mellitus (OPTIMAL) study has been designed (Japan Registry of Clinical Trials: jRCT1052180152, University Hospital Medical Information Network Clinical Trial Registry UMIN000036721). Methods The OPTIMAL is a single-center, randomized trial to evaluate the efficacy of CGM-based glycemic control on atheroma progression in T2DM patients with CAD by using serial intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS) imaging. A total of 90 eligible subjects will be randomized 1:1 into two groups to receive either CGM-based glycemic control or HbA1c-baded glycemic management. Coronary angiography and NIRS/IVUS imaging is repeated at the end of the assigned treatment period. Results The primary endpoint is the normalized absolute change in total atheroma volume (TAV) from baseline to 12 months. The secondary endpoints include (I) the absolute change in percent atheroma volume, (II) the percent change in lipid core burden index, (III) the change in coefficient variance measured by CGM, (IV) the change in atherogenic markers (high-density lipoprotein functionality, proprotein convertase subxilisin/kexin type 9 and fatty-acid binding proteins), and (V) the frequency of hypoglycemia. Safety will also be evaluated. Conclusions The collaboration of CGM use with serial NIRS/IVUS imaging will enable to compare atheroma progression rate under CGM-based glycemic management and HbA1c-based approach.
Collapse
|
27
|
Noguchi M, Shitara K, Kawazoe A, Yamamoto D, Takii Y, Saito Y, Sato T, Horimatsu T, Ishikawa H, Ito Y, Ito M, Ikematsu H. A phase II trial of adjuvant chemoradiotherapy for patients with high-risk rectal submucosal invasive cancer after local resection. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz421.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
28
|
Nagata Y, Kinoshita C, Ishimoto U, Kano T, Ishikawa M, Mikuni H, Nakatsuka K, Harada K, Nishimura T, Noguchi M, Sawada R, Amano K, Saruta M. Details of response with first-line gemcitabine and nab-paclitaxel therapy in patients with advanced pancreatic cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz422.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
29
|
Suekane S, Noguchi M, Terasaki M, Yutani S, Narita Y, Yamada A, Shichijo S, Igawa T, Itoh K. Biomarkers predictive of overall survival in advanced cancer patients treated with a peptide-based cancer vaccine. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz239.048] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
30
|
Yoshiyama K, Noguchi M, Terasaki M, Sugawara S, Yamada A, Shichijo S, Takamori S, Akagi Y, Yutani S, Itoh K. P2.04-65 Peptide-Based Cancer Vaccine Shortened the Overall Survival of a Large Portion, but Not All, of Advanced Cancer Patients. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
31
|
Minami Y, Muratani M, Sato Y, Shiozawa T, Usui S, Hayashihara K, Noguchi M. P2.11-34 Application of Next-Generation Sequencing for Screening of Sputum Samples. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Kosibaty Z, Murata Y, Minami Y, Noguchi M. P2.14-22 Loss of Ect2 Expression Impairs Cell-Matrix Adhesion and FAK/Src Signaling in Lung Adenocarcinoma Cells. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
33
|
Kim Y, Shiba-Ishii A, Noguchi M. MA18.01 Patient-Derived Xenografts of Lung Squamous Cell Carcinoma Show a Characteristic Genetic Profile Indicating a Specific Biological Subtype. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
34
|
Dai T, Adachi J, Minami Y, Tomonaga T, Noguchi M. MA18.09 Protein Profiling of Small Lung Adenocarcinomas: An In-Depth Analysis. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
35
|
Hong J, Kim Y, Shiba-Ishii A, Noguchi M. P1.03-18 OCIAD2 Impairs Mitochondria-Mediated Apoptosis Through Substantial Alteration of Crista Structure in Lung Adenocarcinoma. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.870] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
36
|
Noguchi M, Fukatsu K, Watkins A, Watanabe T, Higashizono K, Murakoshi S. MON-PO378: Does Enteral Feeding Improve Outcome of Mice with Carcinomatous Peritonitis? Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32212-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
37
|
Watkins A, Fukatsu K, Noguchi M, Higashizono K, Murakoshi S. SUN-PO080: Whey Protein Worsens Survival of Mice with Carcinomatous Peritonitis by Enhancing PD-1 Receptor Expression on CD8 + T Cell. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32714-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
38
|
Noguchi M, Chen-Yoshikawa T, Kayawake H, Yamada Y, Yutaka Y, Nakajima D, Hamaji M, Ohsumi A, Date H. Reconsidering Indication of Lung Transplantation for Late-Onset Noninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.547] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
39
|
Fitzgibbon-Collins LK, Brar I, Noguchi M, McIlroy W, Heckman G, Hughson R. CEREBROVASCULAR HEMODYNAMICS, POSTURAL STABILITY AND FALLS IN OLDER ADULTS. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Matsuoka R, Shiba A, Sakashita S, Minami Y, Noguchi M. P1.09-30 Heterotopic Expression of Ceruloplasmin in Lung Adenocarcinoma and its Possible Clinical Use as a Tumor Biomarker. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
41
|
Sakashita S, Masahiro M, Matsuoka R, Muratani M, Noguchi M. P1.09-16 Novel Somatic Gene Mutation of SLC17A9, Detected in Early-Stage Lung Adenocarcinoma. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
42
|
Noguchi M. P1.04-06 Clinicopathological Analysis of Pulmonary Pleomorphic Carcinoma. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
43
|
Takahashi K, Nishikawa S, Miyata R, Noguchi M, Ishikawa H, Yutaka Y, Nakajima D, Hamaji M, Ohsumi A, Menju T, Chen-Yoshikawa F, Sato T, Sonobe M, Date H. Tranilast inhibits TGF-beta-induced EMT and invasion/metastasis via the suppression of smad4 in lung cancer cell lines. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy268.035] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
44
|
Menju T, Sowa T, Imamura N, Nishikawa S, Takahashi K, Miyata R, Ishikawa H, Noguchi M, Hamaji M, Nakajima D, Ohsumi A, Sato T, Chen-Yoshikawa T, Sonobe M, Date H. P3.09-13 Molecular Profiling Suggests the Different Mechanisms Among Local Invasiveness in Resected Human Lung Adenocarcinoma. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Minami Y, Noguchi M, Association I. P1.09-05 Why does PD-L1 (22C3) expression rate show difference among regional hospitals? J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.781] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
46
|
Nishikawa S, Menju T, Sowa T, Nakanishi T, Takahashi K, Miyata R, Ishikawa H, Noguchi M, Yutaka Y, Hamaji M, Nakajima D, Ohsumi A, Sato T, Yoshikawa T, Sonobe M, Date H. P2.03-29 Prognostic Significance of Phosphorylated Fyn in Patients with Lung Adenocarcinoma. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
47
|
Noguchi M. MS05.02 Defining Invasion in Minimally Invasive Adenocarcinoma. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
48
|
Noguchi M, Fukatsu K, Watkins A, Murakoshi S, Watanabe T, Higashizono K, Yasuhara H. A low carbohydrate high fat diet impairs gut immunity both in normal and carcinomatous peritonitis mice. Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.1714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
49
|
Noguchi M, Fukatsu K, Watkins A, Murakoshi S, Watanabe T, Higashizono K, Yasuhara H. Does a low carbohydrate high fat diet affect gut morphology in mice with carcinomatous peritonitis? Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.1713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
50
|
Watkins A, Fukatsu K, Watanabe T, Higashizono K, Murakoshi S, Noguchi M, Yasuhara H. Influences of different types of high fat diets on anti-cancer immunity in a murine carcinomatous peritonitis model. Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.1304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|